Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Alcohol use disorders (AUDs) are a major problem facing our society. Their treatment is
complex, and involves multiple behavioral and pharmacotherapy interventions. There are 3
approved medications for AUDs, but their efficacy for AUDs that co-exist with anxiety
disorders is unknown. This study explores the effects of the medication, sustained-release
quetiapine fumarate (Seroquel SR) for the treatment of alcohol dependence and co-morbid
anxiety. Primary outcome measure is the amount of alcohol used. Secondary outcome measures
include craving for alcohol, length of sobriety from drinking and level of anxiety with
Seroquel SR.